The Access to COVID-19 Tools (ACT) Accelerator has announced a set of agreements to make COVID-19 rapid antigen tests available to low- and middle-income countries. The rapid antigen tests, developed by Abbott and SD Biosensor, are highly portable, reliable, and easy to administer, making testing possible in near-person, decentralised healthcare settings, and will help countries … Continue reading Global agreement to make COVID-19 antigen tests available for all